Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
The analysis highlights History, Research, Companies and Art as prominent areas in the source structure around Novartis.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Novartis shows recurring relationship patterns in the source. For example, Novartis → Acq, Admune Therapeutic, Advanced Accelerator Applications, Alcon, Amblyotech, Anthos Therapeutics, Arctos Medical, Aspen Global, Ataxion Therapeutics, AveXis, Avidity Biosciences, Cadent Therapeutics, Cancer, CellforCure, Cetus CorporationCetus OncologyBiocine CompanyChiron, Chinook Therapeutics, Chiron Corporation, CIBA, Ciba-Geigy, Ciba-GeigyJ Another extracted example is Novartis → According, ADHD, American Medical Association, But, Columbia, Diovan, Drug Administration, Exforge, FDA, February, Federal, Focalin XR, Frank Lichtenberg, In, In September, Inspector General, New York Times, Novartis Pharmaceuticals, Sandostatin, So. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
sandoz company announced billion drug million pharmaceutical would also us drugs acquire business patent ciba-geigy new companies 2023 gleevec pharmaceuticals
TTTA extracted 346 structured relationships around Novartis. Examples in this analysis include Novartis → Area served → Worldwide and Novartis → Founded → 20 December 1996; 29 years ago (1996-12-20) (from merger). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Novartis | Area served | Worldwide | 1.00 | infobox |
| Novartis | Founded | 20 December 1996; 29 years ago (1996-12-20) (from merger) | 1.00 | infobox |
| Novartis | Founders | Johann Rudolf | 1.00 | infobox |
| Novartis | Founders | Alexander Clavel | 1.00 | infobox |
| Novartis | Headquarters | Basel, Switzerland (.mw-parser-output .geo-default,.mw-parser-output .geo-dms,.mw-parser-output .geo-dec{display:inline}.mw-parser-output .geo-nondefault,.mw-parser-output .geo-… | 1.00 | infobox |
| Novartis | Industry | Pharmaceuticals | 1.00 | infobox |
| Novartis | ISIN | CH0012005267 | 1.00 | infobox |
| Novartis | Key people | Vasant Narasimhan (CEO) | 1.00 | infobox |
| Novartis | Key people | Giovanni Caforio (chairman) | 1.00 | infobox |
| Novartis | Net income | US$11.94 billion (2024) | 1.00 | infobox |
| Novartis | Number of employees | 75,883 (2024) | 1.00 | infobox |
| Novartis | Operating income | US$14.54 billion (2024) | 1.00 | infobox |
| Novartis | Predecessors | Ciba-Geigy | 1.00 | infobox |
| Novartis | Predecessors | Sandoz (via merger) | 1.00 | infobox |
| Novartis | Products | Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...) | 1.00 | infobox |
| Novartis | Revenue | US$50.32 billion (2024) | 1.00 | infobox |
| Novartis | Total assets | US$101.2 billion (2024) | 1.00 | infobox |
| Novartis | Total equity | US$44.13 billion (2024) | 1.00 | infobox |
| Novartis | Traded as | SIX: NOVN | 1.00 | infobox |
| Novartis | Traded as | SMI component | 1.00 | infobox |
| Novartis | Traded as | NYSE: NVS (ADR) | 1.00 | infobox |
| Novartis | Type | Public | 1.00 | infobox |
| Novartis | Website | novartis.com | 1.00 | infobox |
| Novartis | is a | full member of the European Federation of Pharmaceutical Industries and Associations | 0.90 | text |
| Novartis | is a | third most valuable pharmaceutical company in Europe | 0.90 | text |
The concept neighborhoods around Novartis bring nearby vocabulary together. In this analysis, examples include Announced, Billion and Company. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Novartis, one of the stronger structural bridges in this analysis connects Novartis with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Novartis to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Research, Companies & Art, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Novartis · EN edition · Analysis: TopicsToTalkAbout